GlennBubleyMD

Clinical Trials

• Ketoconazole, Hydrocortisone, Dutasteride and Lapatinib (KHAD-L) in Prostate Cancer Start of enrollment: 2009 Sep 29

  Terminated

  Phase 1, Phase 2

• Docetaxel Followed by Radical Prostatectomy in Patients With High Risk Localized Prostate Cancer Start of enrollment: 2001 Jan 01

  Completed

  Phase 2

• Effects of Two Doses of MPX Capsules on Rising Prostate-specific Antigen Levels in Men Following Initial Therapy for Prostate Cancer Start of enrollment: 2011 Jul 01

  Completed

  Phase 1, Phase 2

• A 2 Part, Phase 2 Trial of Galeterone in the Treatment of Castration Resistant Prostate Cancer Start of enrollment: 2012 Dec 01

  Terminated

  Phase 2

• BKM120+Abiraterone Acetate for Metastatic CRPC Start of enrollment: 2012 Nov 01

  Terminated

  Phase 1

• Study of Enzalutamide in Patients With Castration-resistant Prostate Cancer Start of enrollment: 2013 Sep 13

  Completed

  Phase 2

• Enzalutamide + External Beam Rt For Prostate Start of enrollment: 2014 Feb 01

  Completed

  Phase 2

• A Study of Docetaxel + ARN-509 in Castration-Resistant Prostate Cancer Start of enrollment: 2017 Jun 23

  Terminated

  Phase 2

• Study Evaluating the Addition of Pembrolizumab to Radium-223 in mCRPC Start of enrollment: 2017 Jun 09

  Active, not recruiting

  Phase 2

• Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors Start of enrollment: 2017 Dec 28

  Active, not recruiting

  Phase 2

• INTREPId (INTermediate Risk Erection PreservatIon Trial) Start of enrollment: 2020 Jun 01

  Recruiting

  Phase 2

• Join now to see all